Report Description
The global anesthesia drug market size was valued at USD 5.59 billion in 2022 and is expected to surpass USD 7.62 billion by 2031, expanding at a CAGR of 3.5% during the forecast period, 2023–2031. The growth of the market is attributed to increasing geriatric population and growing prevalence of chronic diseases. Moreover, improving access to healthcare facilities is driving the market growth.
Anesthesia is the practice of administering medicines that block the feeling of sensation, which in turn, allows medical or surgical operations to take place without causing undue distress or discomfort.
Anesthesia can be used for minor procedures, such as filling a tooth. It could be used during childbirth or procedures such as colonoscopies. In some cases, a dentist, nurse, or doctor may give you an anesthetic. In other cases, an anesthesiologist doctor administers anesthesia in special cases.
Local anesthesia drug numbs a small part of the body. It might be used on a tooth that or on a small area around the wound that needs stitches. Regional anesthesia drugs are used for larger areas of the body such as an arm, a leg, or below the waist. General anesthesia drug affects the whole body. It makes the patient unconscious. It is used during major surgeries, such as heart surgery, brain surgery, back surgery, and organ transplants.
Market Trends, Drivers, Restraints, and Opportunities:
-
Rising number of surgeries is one of the major drivers that is contributing to the growth of the global anesthesia drug market.
-
Increasing number of anesthesia drug approvals is expected to augment the global anesthesia drug market growth.
-
Side effects of anesthesia drugs can restraint the growth of the market.
-
Lack of skilled anesthesiologist can create challenges for the market growth.
-
The outbreak of COVID-19 has negatively impacted the global anesthesia drug market. However, the market is anticipated to recover soon.
Scope of the Report
The report on the global anesthesia drug market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Anesthesia Drug Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Drug Types (General Anesthesia Drugs and Local Anesthesia Drugs), Route of Administration (Inhalation, Injection, and Others), and Applications (General Surgery, Cosmetic Surgery, Plastic Surgery, Dental Surgery, and Others)
|
Regional scope
|
North America, Latin America, Europe, Asia Pacific, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Abbott Laboratories, Baxter, Abbott Laboratories, AstraZeneca, Roche Holding AG, B. Braun Melsungen AG, Aspen Pharmacare Holdings Limited, and Fresenius SE & Co. KGaA.
|
Global Anesthesia Drug Market Segment Insights:
General anesthesia segment to grow at a rapid pace
Based on drug types, the market is divided into general anesthesia drugs and local anesthesia drugs. The general anesthesia drugs segment is anticipated to account for a key market share and is anticipated to grow at a steady rate during the forecast period. This type of drug reduces patient awareness to the surgical procedure, provides proper muscle relaxation, controls the airway, breathing, and circulation, and enables rapid administration.
Inhalation segment to account a major market share
Based on route of administration, the market is segmented into inhalation, injection, and others. The inhalation segment is anticipated to account for a major market share in the projected timeline. Inhalational anesthetics provide amnesia and immobility, except for nitrous oxide, which provides analgesia. Inhaled anesthetics are commonly used in combination with IV anesthetic agents.
These agents have FDA approval for use as a general anesthetic and sedation agent in the operating room. Inhaled anesthetic agents are also used in the intensive care unit, but this is not an FDA-approved indication. The primary applications of inhaled anesthetic agents in the ICU are sedation, refractory bronchospasm, and control of status epilepticus unresponsive to anticonvulsant medications.
General surgery segment to exhibit a high CAGR
Based on applications, the market is segregated into general surgery, cosmetic surgery, plastic surgery, dental surgery, and others. The general surgery segment is projected to exhibit a high CAGR during the forecast period. Growing number of accidents is expected to drive the growth of the market segment.
On the other hand, the cosmetics surgery segment is expected to grow at a healthy rate owing to increasing number of people opting for cosmetic surgeries to improve facial appearance.
North America to account a considerable market share
On the basis of regions, the market is classified as North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America to account for a considerable market share owing to increasing number of surgeries, rising aging population, growing prevalence of chronic diseases, and advancements in anesthesia technologies.
As per the statistics provided by the American Society of Plastic Surgeons (ASPS) 2019, almost 1.76 million cosmetic surgical procedures and 16.2 million cosmetic minimally-invasive procedures were performed in the United States in 2019.
Segments
The global anesthesia drug has been segmented on the basis of
Drug Types
- General Anesthesia Drugs
- Local Anesthesia Drugs
Route of Administrations
- Inhalation
- Injection
- Others
Applications
- General Surgery
- Cosmetic Surgery
- Plastic Surgery
- Dental Surgery
- Others
Regions
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Key Players
- Abbott Laboratories
- Baxter
- Abbott Laboratories
- AstraZeneca
- Roche Holding AG
- B. Braun Melsungen AG
- Aspen Pharmacare Holdings Limited
- Fresenius SE & Co. KGaA.
Competitive Landscape
The major players of the market are Abbott Laboratories, Baxter, Abbott Laboratories, AstraZeneca, Roche Holding AG, B. Braun Melsungen AG, Aspen Pharmacare Holdings Limited, and Fresenius SE & Co. KGaA.
Table Of Content
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Anesthesia Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Anesthesia Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Anesthesia Drug Market - Supply Chain
4.5. Global Anesthesia Drug Market Forecast
4.5.1. Anesthesia Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Anesthesia Drug Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Anesthesia Drug Market Absolute $ Opportunity
5. Global Anesthesia Drug Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Anesthesia Drug Market Size and Volume Forecast by Applications
5.3.1. General Surgery
Cosmetic Surgery
Plastic Surgery
Dental Surgery
Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Anesthesia Drug Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Anesthesia Drug Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Anesthesia Drug Demand Share Forecast, 2019-2026
7. North America Anesthesia Drug Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Anesthesia Drug Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Anesthesia Drug Market Size and Volume Forecast by Applications
7.4.1. General Surgery
Cosmetic Surgery
Plastic Surgery
Dental Surgery
Others
7.5. Basis Point Share (BPS) Analysis by Applications
7.6. Y-o-Y Growth Projections by Applications
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Anesthesia Drug Demand Share Forecast, 2019-2026
8. Latin America Anesthesia Drug Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Anesthesia Drug Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Anesthesia Drug Market Size and Volume Forecast by Applications
8.4.1. General Surgery
Cosmetic Surgery
Plastic Surgery
Dental Surgery
Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Anesthesia Drug Demand Share Forecast, 2019-2026
9. Europe Anesthesia Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Anesthesia Drug Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Anesthesia Drug Market Size and Volume Forecast by Applications
9.4.1. General Surgery
Cosmetic Surgery
Plastic Surgery
Dental Surgery
Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Anesthesia Drug Demand Share Forecast, 2019-2026
10. Asia Pacific Anesthesia Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Anesthesia Drug Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Anesthesia Drug Market Size and Volume Forecast by Applications
10.4.1. General Surgery
Cosmetic Surgery
Plastic Surgery
Dental Surgery
Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Anesthesia Drug Demand Share Forecast, 2019-2026
11. Middle East & Africa Anesthesia Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Anesthesia Drug Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Anesthesia Drug Market Size and Volume Forecast by Applications
11.4.1. General Surgery
Cosmetic Surgery
Plastic Surgery
Dental Surgery
Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Anesthesia Drug Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Anesthesia Drug Market: Market Share Analysis
12.2. Anesthesia Drug Distributors and Customers
12.3. Anesthesia Drug Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Abbott Laboratories
Baxter
Abbott Laboratories
AstraZeneca
Roche Holding AG
B. Braun Melsungen AG
Aspen Pharmacare Holdings Limited
Fresenius SE & Co. KGaA.